SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4.
View / Open Files
Authors
Aspris, Demetrios
Liu, Wen-Hsin
Gozdecka, Malgorzata
Metzakopian, Emmanouil
Dudek, Monika
Robson, Samuel C
Hermida-Prado, Francisco
Yang, Yu Hsuen
Babaei-Jadidi, Roya
Garyfallos, Dimitrios A
Seiler, Michael
Buonamici, Silvia
Rad, Roland
Correia Antunes Pina, Cristina Pina
Yusa, Kosuke
Publication Date
2018-12-19Journal Title
Nature communications
ISSN
2041-1723
Volume
9
Issue
1
Pages
5378
Language
eng
Type
Article
This Version
VoR
Physical Medium
Electronic
Metadata
Show full item recordCitation
Tzelepis, K., De Braekeleer, E., Aspris, D., Barbieri, I., Vijayabaskar, M., Liu, W., Gozdecka, M., et al. (2018). SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4.. Nature communications, 9 (1), 5378. https://doi.org/10.1038/s41467-018-07620-0
Keywords
HL-60 Cells, K562 Cells, Chromatin, Humans, Protein-Serine-Threonine Kinases, Cell Cycle Proteins, Nuclear Proteins, Protein Isoforms, Transcription Factors, Cell Differentiation, Hematopoiesis, Epigenesis, Genetic, RNA Splicing, Leukemia, Myeloid, Acute, Cell Cycle Checkpoints
Sponsorship
Leukemia & Lymphoma Society (7001-12)
Kay Kendall Leukaemia Fund (KKL888)
MRC (MC_PC_12009)
WELLCOME TRUST (109967/Z/15/Z)
Medical Research Council (MR/M010392/1)
MRC (MR/R009708/1)
European Research Council (268569)
Wellcome Trust (092096/Z/10/Z)
Cancer Research UK (A14492)
Cancer Research UK (23015)
Identifiers
External DOI: https://doi.org/10.1038/s41467-018-07620-0
This record's URL: https://www.repository.cam.ac.uk/handle/1810/287707